✦ LIBER ✦

The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects

✍ Scribed by Hamilton, Marta; Wolf, Julie L.; Drolet, Daniel W.; Fettner, Scott H.; Rakhit, Ashok K.; Witt, Karsten; Lum, Bert L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of CYP3A4 inducers with and with

✍ Samantha Abel; Timothy M. Jenkins; Lyndsey A. Whitlock; Caroline E. Ridgway; Gar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

274 EFFECT OF A MODERATE CYP3A4 INHIBITO

✍ B. Malhotra; C. Alvey; Z. Jumadilova; X. Li; K. Gandelman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Effects of the moderate CYP3A4 inhibitor

✍ Bimal Malhotra; Maurice Dickins; Christine Alvey; Zhanna Jumadilova; Xiaoxi Li; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 829 KB

Effect of rifampicin on the pharmacokine

✍ Renli Teng, Patrick Mitchell, Kathleen Butler 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 286 KB

Effects of CYP3A4 inhibitors on the phar

✍ Samantha Abel; Deborah Russell; Richard J. Taylor-Worth; Caroline E. Ridgway; Ga 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

Effect of bifendate on the pharmacokinet

✍ Zeng, Yong; He, Yi-jing; He, Fu-yuan; Fan, Lan; Zhou, Hong-hao 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 Chinese ⚖ 287 KB